Unjha Formulations Financial Results
Unjha Formulations filed the XBRL/XML financial statements for year ended 31/03/2026 with BSE. The submission includes Balance Sheet, P&L, and Cash Flow under SEBI LODR.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Unjha Formulations filed the XBRL/XML financial statements for year ended 31/03/2026 with BSE. The submission includes Balance Sheet, P&L, and Cash Flow under SEBI LODR.
Unjha Formulations Limited filed its shareholding distribution schedule as of March 31, 2026, pursuant to SEBI regulations. This is a routine compliance disclosure regarding shareholder distribution.
Unjha Formulations Limited conducted its 32nd Annual General Meeting on August 14, 2026. Members transacted business including the adoption of financial statements and director appointments.
Unjha Formulations Limited has scheduled its Annual General Meeting for August 14, 2026. Agenda items include the adoption of financial statements and related party transactions worth ₹2.00 Crore.
Unjha Formulations Ltd reported revenue from operations of ₹3.3 Cr (-8.3% YoY) and net profit of ₹0.2 Cr (-50.0% YoY) for Q1 FY27.
Unjha Formulations Ltd reported revenue from operations of ₹3.3 Cr (-8.3% YoY) and net profit of ₹0.2 Cr (-50.0% YoY) for Q1 FY27.
Unjha Formulations Limited has scheduled its 32nd Annual General Meeting for August 14, 2026. The company fixed August 7, 2026, as the cut-off date for e-voting entitlement.
Unjha Formulations submitted its 32nd Annual Report for FY 2025-26. The report includes a notice for the 32nd Annual General Meeting scheduled for August 14, 2026.
Unjha Formulations Limited has scheduled its 32nd Annual General Meeting for August 14, 2026. The meeting will address financial statements and management appointments.
Unjha Formulations scheduled a board meeting on August 3, 2026. The board will consider unaudited financial results for the quarter ended June 30, 2026.
Unjha Formulations clarified that recent share price movements are purely market-driven. The company confirmed it has no undisclosed price-sensitive information affecting performance or operations.